Clinical Trials Sponsored by Aetas Pharma Co. Ltd.

Total 711 results

Sunshine Lake Pharma Co., Ltd.

Completed

ADME Study of [14C]- Larotinib in Healthy Male Subjects

Healthy Adult Male Volunteers

China
Sunshine Lake Pharma Co., Ltd.

Completed

Pharmacokinetics of Midazolam When Co-administered With HEC74647 and HEC110114

Healthy Subjects

China
Sunshine Lake Pharma Co., Ltd.

Completed

A Clinical Study Comparing the Pharmacokinetics and Pharmacodynamic Characteristics of Insulin Degludec Injection (RD15003) and Insulin Degludec Injection (Tresiba®) in Healthy Subjects

Type 2 Diabetes

China
Sunshine Lake Pharma Co., Ltd.

Completed

Clinical Study of HEC68498 in Patients With Advanced Refractory Solid Tumors

Advanced Refractory Solid Tumors

China
Sunshine Lake Pharma Co., Ltd.

Completed

GLS4/RTV and TAF Drug-drug Interaction

Chronic Hepatitis B

China
Sunshine Lake Pharma Co., Ltd.

Terminated

Gemcitabine and Z650 in Treating Patients With Metastatic or Recurrent Pancreatic Cancer

Pancreatic Cancer

China
Sunshine Lake Pharma Co., Ltd.

Completed

Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC585 in Healthy Male and Female Subjects

Idiopathic Pulmonary Fibrosis

China
Orient Pharma Co., Ltd.
Durect

Completed

Evaluate Safety and Efficacy of ORADUR®-Methylphenidate in Children and Adolescents With ADHD

Attention Deficit Hyperactivity Disorder

Taiwan
Taizhou EOC Pharma Co., Ltd.

Active, not recruiting

Ph3 Study of Exemestane With or Without Entinostat in Chinese Patients With Hormone Receptor-Positive, Locally Advanced or Metastatic Breast Cancer

Advanced Breast Cancer

China
Sunshine Lake Pharma Co., Ltd.

Completed

Multiple Dose Safety, Tolerability, PK，PD and Food Effect Study of HEC96719 in Healthy Adult Subjects

Nonalcoholic Steatohepatitis (NASH)

China
Sunshine Lake Pharma Co., Ltd.

Completed

The Tolerability , Pharmacokinetics and Pharmacodynamics Study of HEC96719 Tablets in Healthy Adult Subjects

Nonalcoholic Steatohepatitis (NASH)

China
Sunshine Lake Pharma Co., Ltd.

Completed

The Safety, Tolerability, and Pharmacokinetics Study of HEC113995 PA•H2O Tablets in Healthy Subjects

Major Depressive Disorder

China
Sunshine Lake Pharma Co., Ltd.

Completed

First-In-Human Phase I Trial of Ningetinib ( CT053PTSA ) in the Patients With Advanced Solid Tumors

Advanced Solid Tumors

China
Sunshine Lake Pharma Co., Ltd.

Completed

The Safety, Tolerability and Pharmacokinetic Study of Litapiprant Tablets in Healthy Male and Female Subjects

Asthma

China
Sunshine Lake Pharma Co., Ltd.

Completed

The Safety, Antiviral Activity, and Pharmacokinetics of Morphothiadine Mesilate Capsules

Chronic Hepatitis B

China
Sunshine Lake Pharma Co., Ltd.

Completed

The Tolerability and Pharmacokinetics Study of Kangdaprevir Sodium Tablet in Healthy Adult Subjects

Chronic Hepatitis c

China
Sunshine Lake Pharma Co., Ltd.

Completed

Phase 3 Study of Yimitasvir Phosphate Capsules

Chronic HCV Infection

China
Sumitomo Pharma (Suzhou) Co., Ltd.

Completed

A Clinical Trial of Lurasidone in Treatment of Schizophrenia

Schizophrenia

China
Sumitomo Pharma (Suzhou) Co., Ltd.

Completed

Effect of Arotinolol Hydrochloride on Cardiovascular Events in Hypertensive Haemodialysis Patients (AHOCEP)

Chronic Kidney Disease

China
Sunshine Lake Pharma Co., Ltd.

Unknown

The Study of a Selective 5-ht6 Receptor Antagonist, HEC30654AcOH,in Healthy Subjects

Healthy

China
Techpool Bio-Pharma Co., Ltd.

Unknown

The Study to Reevaluate the Safety and Efficacy of Human Urinary Kallikrein

Cerebral Infarction

China
Takeda
EA Pharma Co., Ltd.

Completed

A Phase II/III, Double-blind, Parallel Group Comparative Study of Oral Administration of NE-58095 Tablets

Involutional Osteoporosis

Japan
Meiji Seika Pharma Co., Ltd.

Completed

Intrapulmonary Pharmacokinetics of ME1100 in Healthy Volunteers

Healthy

United States
Meiji Seika Pharma Co., Ltd.

Completed

Pharmacokinetics and Safety Study of ME1100 in Healthy Volunteers

Healthy

United States
Meiji Seika Pharma Co., Ltd.

Completed

Pharmacokinetics and Safety Study of ME1111 in Moderate to Severe Onychomycosis Patients

Onychomycosis

United States
Hanlim Pharm. Co., Ltd.

Recruiting

Study to Evaluate Efficacy and Safety of Bronpass Tab. in Patients With Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease

Korea, Republic of
Hanlim Pharm. Co., Ltd.

Recruiting

An Observation Study on the Identification of Prescription Patterns of Lodient Tab(Telmisartan/S-amlodipine)

Hypertension

Korea, Republic of
Hanlim Pharm. Co., Ltd.

Recruiting

The Prescription Patterns and Clinical Efficacy of Tenero Tab/Tenero M SR Tab

Diabetes Mellitus, Type 2

Korea, Republic of
Hanlim Pharm. Co., Ltd.

Recruiting

Observational Study on the Improvement of Dry Eye Syndrome, Treatment Satisfaction, and Intraocular Tolerance With Diquasol Eye Drops

Dry Eye Syndrome

Korea, Republic of
ST Pharm Co., Ltd.

Recruiting

A Clinical Trial of STP0404 in Adults With HIV-1 Infection

HIV-1-infection

United States
AJU Pharm Co., Ltd.

Recruiting

A Clinical Trial to Evaluate the Safety and Pharmacokinetics of AJU-C52H in Healthy Volunteers

Hypertension

Korea, Republic of
Yungjin Pharm. Co., Ltd.

Completed

A Phase 2a Study to Assess Safety, Daily Symptoms, PK, and Biomarkers of YPL-001 in COPD Patients

Chronic Obstructive Pulmonary Disease

United States
Hanlim Pharm. Co., Ltd.

Completed

To Evaluate the Efficacy and Safety of LuminoMark Injection in Patients With Nonpalpable Breast Lesions(Phase 3)

Breast Diseases

Korea, Republic of
Hanlim Pharm. Co., Ltd.

Completed

Study to Evaluate the Safety and PK of LODIENT Tablet 80/2.5mg in Healthy Adult Volunteers

Hypertension

Korea, Republic of
Hanlim Pharm. Co., Ltd.

Unknown

To Evaluate the Efficacy and Safety of Co-administrated Ezetimibe/Rosuvastatin and Telmisartan in Patients With Essential Hypertension and Primary Hypercholesterolemia

Hypertension | Primary Hypercholesterolemia

Korea, Republic of
Hanlim Pharm. Co., Ltd.

Unknown

The Study of Pharmacokinetic Interactions Between HL237 and Tacrolimus

Healthy Male Volunteers

Korea, Republic of
Hanlim Pharm. Co., Ltd.

Unknown

Phase 2a Clinical Trial to Evaluate the Efficacy and Safety of HL301 on Radiation Pneumonitis in Non-small Cell Lung Cancer Patients

Lung Cancer | Radiation Pneumonitis

Korea, Republic of
Hanlim Pharm. Co., Ltd.

Completed

Study to Evaluate HL-TOF Tab. 5 mg Compared With XelJanz Tab. in Healthy Volunteers

Healthy Volunteers

Korea, Republic of
Hanlim Pharm. Co., Ltd.

Completed

Evaluation of the Efficacy and Safety of Entelon Tab. 150mg in Patients With Osteoarthritis of Knee

Knee Osteoarthritis

Korea, Republic of
Hanlim Pharm. Co., Ltd.

Completed

The Pharmacokinetic Interaction Between Celecoxib and Rebamipide

Healthy Male Volunteers

Korea, Republic of
Hanlim Pharm. Co., Ltd.

Completed

Single Dosing Clinical Trial of HL151

Rhinitis, Allergic, Perennial

Korea, Republic of
Hanlim Pharm. Co., Ltd.

Completed

Efficacy and Safety of Combination of Rosuvastatin and Ezetimibe in Patients With Primary Hypercholesterolemia

Primary Hypercholesterolemia
Hanlim Pharm. Co., Ltd.

Completed

A Clinical Trial to Evaluate the Efficacy and Safety of Pitavastatin/Fenofibrate in Complex-dyslipidemia

Complex-dyslipidemia
Hanlim Pharm. Co., Ltd.

Completed

The Pharmacokinetic Study of the Fixed-dose Combination of Micronized Fenofibrate and Pitavastatin Ca

Healthy Male Volunteers

Korea, Republic of
Hanlim Pharm. Co., Ltd.

Completed

Evaluation of Pharmacokinetic Interaction Between Micronized Fenofibrate and Pitavastatin

Healthy Male Volunteers

Korea, Republic of
Yungjin Pharm. Co., Ltd.

Completed

Safety, Tolerability and Pharmacokinetic Study of KL1333 in Healthy Male Volunteers

MELAS Syndrome | Mitochondrial Respiratory Chain Deficiencies

Korea, Republic of
Yungjin Pharm. Co., Ltd.

Completed

Safety, Tolerability and Pharmacokinetic Study of MB12066 in Healthy Male Volunteers

Metabolic Syndrome

Korea, Republic of
Yungjin Pharm. Co., Ltd.

Completed

Phase 2 Study to Evaluation the Safety and Efficacy of Orally Administered KL7016 in Patients With Dry Eye Syndrome

Dry Eye Syndrome

Korea, Republic of
Hanlim Pharm. Co., Ltd.

Completed

A Multicenter, Randomized, Double-blind, Parallel Group Study to Determine the Optimal Dose of HL301 After 7 Days Oral Administration in Acute Bronchitis or Acute Exacerbations of Chronic Bronchitis Patients (HL301: Mixed Extract of Rehmannia Glutinosa, Schisandra and so on) (HL301)

Acute Exacerbations of Chronic Bronchitis | Acute Bronchitis

Korea, Republic of
PMG Pharm Co., Ltd

Completed

To Compare the Efficacy and Safety of LAYLA in Osteoarthritis Patients

Osteoarthritis of the Knee

Korea, Republic of

3

Subscribe